We are a young but ambitious company passionate about delivering the full potential of small activating RNA medicines to patients. We operate as a semi-virtual drug discovery and development company, conducting R&D both internally and externally across an established network of partners and collaborators.

At our core is a close knit team of dedicated individuals working as a highly integrated team. Our culture is deeply meritocratic and rewards high performers that challenge themselves and are driven to make an impact on disease.

Read an interview with our CEO with Oligonucleotide Therapeutics Society: https://www.oligotherapeutics.org/interview-robert-habib/